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ABSTRACT
Аryl hydrocarbon receptor (AHR) is the key transcription factor that controls
animal development and various adaptive processes. The AHR’s target genes are
involved in biodegradation of endogenous and exogenous toxins, regulation of
immune response, organogenesis, and neurogenesis. Ligand binding is important
for the activation of the AHR signaling pathway. Invertebrate AHR homologs are
activated by endogenous ligands whereas vertebrate AHR can be activated by both
endogenous and exogenous ligands (xenobiotics). Several studies using mammalian
cultured cells have demonstrated that transcription of the AHR target genes can be
activated by exogenous AHR ligands, but little is known about the effects of AHR
in a living organism. Here, we examined the effects of human AHR and its ligands
using transgenic Drosophila lines with an inducible human AhR gene. We found
that exogenous AHR ligands can increase as well as decrease the transcription
levels of the AHR target genes, including genes that control proliferation, motility,
polarization, and programmed cell death. This suggests that AHR activation may
affect the expression of gene networks that could be critical for cancer progression
and metastasis. Importantly, we found that AHR target genes are also controlled
by the enzymes that modify chromatin structure, in particular components of the
epigenetic Polycomb Repressive complexes 1 and 2. Since exogenous AHR ligands
(alternatively – xenobiotics) and small molecule inhibitors of epigenetic modifiers
are often used as pharmaceutical anticancer drugs, our findings may have significant
implications in designing new combinations of therapeutic treatments for oncological
diseases.
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INTRODUCTION

activate the Drosophila AHR homolog, this allows the
assessment of their specificity of action by introducing
them into the Drosophila feed medium. Activation of the
human AHR in different Drosophila tissues and organs
allows us to estimate the ability of the human AHR ligands
to regulate transcription of the human AHR target genes
in vivo. It was previously shown that transgenic mouse
AHR and Drosophila ARNT could form a functional
heterodimer capable of inducing dioxin-mediated
activation of AHR target gene homologs in Drosophila
[31]. Here, we demonstrated that AHR activation induced
by different exogenous ligands has pleiotropic effects, i.e.
it can both increase and decrease transcription of the AHR
target genes in different tissues and this effect depends on
the developmental stage of the animal. Importantly, we
found that AHR’s effect on target genes is mediated by
Polycomb group (PcG) epigenetic chromatin regulators.
Thus, the results of this study expand our knowledge
of the in vivo role of the human AHR in the regulation
of development and biodegradation of the toxic agents
and opens up the possibility of using combinations of
xenobiotics and epigenetic inhibitors in the treatment of
a variety of diseases.

Many cellular processes in higher multicellular
organisms depend on the activity of the Aryl hydrocarbon
receptor (AHR); among them are the maintenance
of homeostasis, the regulation of detoxification, cell
division, differentiation, polarization, programmed cell
death, the formation of organ-tissue structures, nervous,
immune, cardiovascular, endocrine, generative, and
excretory systems [1–14]. AHR is a transcription factor
with three functional domains: a highly conserved
N-terminal basic-helix-loop-helix (bHLH) domain, a less
conserved Per/Arnt/Sim (PAS) domain, and a weakly
conserved C-terminal domain [6, 15]. Unliganded human
AHR is localized in the cytoplasm where it is associated
with the molecular chaperons HSP90 (Heat Shock
Protein 90) and XAP2/AIP (X-associated protein 2/AhRinteracting protein). Following binding to the ligand, AHR
translocates to the nucleus, dissociates from HSP90, forms
a heterodimer with the ARNT (Aryl hydrocarbon receptor
nuclear translocator) and binds to specific DNA sequences
known as the Xenobiotic Response Elements.
In humans and mammals, AHR is activated by a
variety of endogenous ligands and xenobiotics (exogenous
ligands) [16–19]. While maintenance of a proper
concentration of the active (liganded) AHR is important
for cell survival and organism functioning [20–24], the
changes in AHR expression are rather frequent events. For
example, aging is often associated with a decrease in the
level of AHR expression. The most dramatic consequences
of the decreased AHR expression are an increased risk of
cancer and the inability to protect cells against the toxic
effects of xenobiotics [25, 26]. Ectopic AHR activation
causes a variety of developmental disorders, e.g.,
abnormal organogenesis and histogenesis, disruptions
in the nervous, immune, cardiovascular, endocrine,
and generative systems. In humans and vertebrates,
the endogenous ligands often function as agonists that
enhance AHR activity. There is a wide range of affinities
of xenobiotic ligands to AHR [27]. Apparently, the ligand
binding affinities can modulate AHR’s ability to activate
target genes [28].
Experiments in cultured cells limit the understanding
of the effects induced by the AHR expression on the
developmental processes in the living organism. To
gain a better understanding of the functioning of AHR
in vivo, we created several ‘humanized’ Drosophila
transgenic animals, which carry transgenes with the
inducible human AhR gene under the control of the yeast
UAS (Upstream Activation Sequence) promoter element.
These transgenic constructs allow the induction of AHR
expression in different organs of Drosophila by using
various tissue-specific GAL4-drivers [29]. It is believed
that in invertebrates, AHR homologs are activated only by
endogenous ligands [4, 30]. Therefore, since the majority
of xenobiotics activating human AHR are not able to
www.impactjournals.com/oncotarget

RESULTS
Strong phenotypic effects of endogenous and
exogenous human AHR ligands in Drosophila
tissues
It is essential to study the effects of xenobiotics on
mammalian AHR in vivo. Drosophila represents a unique
model for these experiments since previous studies have
indicated that dioxin and other xenobiotics, which are
known to bind to the mammalian AHR, were unable to
activate the invertebrate AHR homologue. However,
dioxin affected Drosophila leg and eye development
when the ectopic mouse UAS-AhR was induced by the
dpp-GAL4 and GMR-GAL4 drivers in the primordial leg
or eye tissues, respectively [31]. At the same time, it is
possible that there are some endogenous ligands that are
capable of activating human AHR in other Drosophila
tissues. To investigate this we used a number of GAL4
driver lines to induce human AHR in different Drosophila
tissues. Ubiquitous expression of the UAS-AhR transgene
by tub-GAL4 and Act-GAL4 drivers resulted in embryonic
lethality. Only a few individuals survived to the larval
development stage (Figure 1A). This confirms the
existence of endogenous ligands that can affect the human
AHR activity in Drosophila. Further, the induction of
UAS-AhR expression by the Dll-GAL4 driver caused
complete lethality of the Drosophila pupae, as no adults
could hatch. Examination of the leg morphology of the
unhatched animals confirmed the complete malformation
of the distal leg segments; tarsal segments were missing or
severely malformed (Figure 1B–1C).
102935
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Interestingly, the effects of the endogenous ligands
on the human AHR are limited to a few tissues, as
induction of UAS-AhR ectopic expression by the dppGAL4 driver (without exogenous ligands) only partially
affected wing development (Figure 1H). However, feeding
of animals with the exogenous ligands exacerbated the
abnormal wing phenotype (Figure 1I) and caused strong
leg deformities (Figure 1D–1F). These leg defects were
similar to those caused by the ectopic expression of mouse
UAS-AhR induced by the dpp-GAL4 driver in Drosophila
larvae fed with dioxin [31].
Induction of UAS-AhR expression in the female
germ line with an MTD-gal4 driver, combined
with exposure of MTD-GAL4/UAS-AhR flies to the

exogenous ligands, resulted in a wide range of different
abnormalities during oogenesis. The ovary of the wildtype Drosophila consists of egg tubes called ovarioles
(Figure 2A). The oocyte develops within a group of cells
known as an egg chamber (or follicle), which consists of
a cluster (or cyst) of 16 germ cells (one oocyte and 15
trophocytes) surrounded by an epithelial monolayer of
somatic follicle cells (Figure 2A) [32]. We showed that
the ectopic activation of AHR led to the degradation of
egg chambers that is evident by the presence of pyknotic
nuclei (Figure 2B). The follicular cell layer was often
disorganized (Figure 2C). In some instances, we detected
cysts with 32 trophocytes suggesting that AHR activation

Figure 1: Phenotypic effects of endogenous and exogenous ligands of the human AHR on Drosophila growth and
morphogenesis. (A) Ubiquitous expression of UAS-AhR leads to developmental lethality. The majority of tub>AhR animals die at the

embryonic stage, with very few escapers that die at early larval stages, showing arrest in growth and development. Two four-day old larvae
are shown, the larger one is the control (UAS-AhR/+; UAS-GFP/+, yellow arrow), the smaller green larva (red arrow) is tub>AhR, with
ubiquitous expression of transgenic AHR (UAS-AhR/+; UAS-GFP/Tub-GAL4). The expression pattern of tub-GAL4 is visualized by GFP
expression (green). (B–C). Drosophila leg phenotypes of Dll>AhR flies. (B) control (UAS-AhR/+). (C) Dll>AhR (Dll-GAL4/UAS-AhR).
Flies developed on standard medium with no exogenous ligands. (D–I). Drosophila leg (D–F) and wing (G–I) phenotypes of dpp>AhR
flies. (G) control (UAS-AhR/+). (D–F, H–I) dpp>AhR (dpp-GAL4/UAS-AhR). Flies developed on standard medium without exogenous
ligands (G–H) or with indirubin (D), indinol (E, I) and beta-Naphthoflavone (F). At least 80 legs, 40 wings and more than 20 flies were
analyzed for each genotype. Leg segments are indicated. Note the loss of tarsal segments in (C–D).
www.impactjournals.com/oncotarget
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using the GMR-GAL4 driver. When the GMR-GAL4/
UAS-AhR flies were raised on standard medium with no
exogenous ligands, no defects in eye development were
detected: the ommatidia, i.e., the optical units that make
up a compound adult fly eye, as well as microchaetae
(mechanoreceptors), were packed in a regular array
(Figure 3A–3A′). However, the exposure of the GMRGAL4/UAS-AhR larvae to the exogenous ligands resulted
in a roughened eye phenotype of imagoes (Figure 3B–
3B′, Figure 3C–3C′, Figure 3D–3D′). A morphologically
similar eye phenotype was observed in flies with dioxinmediated expression of mouse AHR induced by the GMRGAL4 driver [31]. It is worth noting that the magnitude
of the eye defects varies depending on the ligand used:

led to an extra round of mitosis during cyst formation
(Figure 2D).
Next, we examined UAS-AhR expression in the
larval nervous system using an Elav-GAL4 driver. The
induction of UAS-AhR expression in the absence of the
exogenous ligands did not affect the morphology of the
Drosophila larval nervous system (Figure 2E). However,
exposure of the UAS-AhR/Elav-GAL4 larvae to the
exogenous ligands resulted in a smaller brain size and in a
shorter ventral nerve cord (Figure 2F), suggesting that the
activation of human AHR in tissues of the nervous system
could hinder their growth and development.
We also examined eye phenotypes of the flies with
induced UAS-AhR expression in the eye imaginal disks

Figure 2: Activation of AHR in germline and nervous systems causes different abnormalities during Drosophila
oogenesis and neurogenesis. (A–D) Confocal sections of the normal ovariole of MTD-GAL4/UAS-AhR female reared on standard

medium (A); degraded egg chamber of MTD-GAL4/UAS-AhR female fed with beta-Naphthoflavone (arrows point on picnotic nuclei) (B);
egg chamber with disordered follicular layer (arrow) from MTD-GAL4/UAS-AhR female reared on medium with indinol (C); follicle with
32 trophocytes (arrow) from MTD-GAL4/UAS-AhR female fed with indirubin (D). Ovaries were stained with SytoxGreen (green) for DNA
visualization and Phalloidin (red) for cytoskeleton visualization. Asterisks, T and FC indicate oocytes, trophocytes, and follicular cells,
respectively. (E–F). Confocal sections of the central nervous system of UAS-mCD8-GFP; UAS-AhR/+; Elav-GAL4/+ larvae merged into
a single 3D-image. Brains of late third instar larvae developed on standard medium (E) or on the medium containing beta-Naphthoflavone
(F). Control brain (E) is significantly bigger than the brain with AhR expression (F). Elav-GAL4 (green, visualized by GFP expression)
drives pan-neuronal expression of transgenic UAS-AhR in brain hemispheres (Br) and the ventral nerve cord (VNC). Magnification scale
bars represent 100 μm in A, E, F and 20 μm in B, C, D.

Figure 3: Drosophila eye phenotypes of GMR>AhR flies. Flies developed on standard medium without exogenous ligands
(A, A′), on medium with indinol (B, B′), beta-Naphthoflavone (C, C′) or indirubin (D, D′). Ommatidia are arranged in a highly regular
pattern in control flies (A–A′), while flies reared on medium with exogenous ligands develop roughened eye phenotypes with irregular
pattern and decreased number of mechanoreceptors (B–D, B′–D′).
www.impactjournals.com/oncotarget
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GMR-GAL4/UAS-AhR flies reared on medium with
indinol, demonstrated more severe abnormalities (Figure
3B–3B′) than those reared on medium with indirubin or
beta-Naphthoflavone (Figure 3C–3C′, Figure 3D–3D′).
Together, these results demonstrate the existence of the
endogenous ligand(s) that is/are capable of activating
induced human AHR in certain Drosophila tissues.
However, in other tissues, AHR can be activated only by
exogenous ligands making Drosophila a valuable model
to study the effects of xenobiotics in vivo, at an organism
level.

To assess the effects of xenobiotics in vivo we
analyzed expression of the AHR target genes in ovaries
of MTD-GAL4/UAS-AhR females fed with exogenous
ligands for 2 days. In these experiments we used betaNaphthoflavone, indirubin and indole-3-carbinol (indinol)
as the human AHR ligands. We found that, depending on
the nature of the exogenous ligand, the induced human
AHR had pleiotropic effects on its target genes. Activation
of the human AHR by indirubin and beta-Naphthoflavone
resulted in the activation of Cyp6g1 and the suppression of
St6Gal and Myc genes. The activation of the human AHR
by indinol resulted in the suppression of St6Gal and the
activation of Myc, Cdc42, dl, Mgat1, and GstT4 (Table 1,
Supplementary Figure 1).
When human AHR was induced in the central
nervous system by the Elav-GAL4 driver in larvae
developed on medium supplemented with indinol or
beta-Naphthoflavone, the expression levels of almost
all of the target genes significantly increased (Table 1,
Supplementary Figure 2). The activation of human
AHR by indirubin resulted in an increase in the levels of
St6Gal, Cyp6g1, dl, Cdc42 and Rbf, but a decrease in the
levels of Mgat1, GstT4, Rel and Jra genes. However, the
induction of human AHR by the Elav-GAL4 driver in adult
brain, combined with feeding with exogenous ligands,
generated less pronounced effects on the expression of
the AHR target genes. The expression of some genes was
not affected by xenobiotics while the expression of other
genes reduced (Table 1, Supplementary Figure 3).
The xenobiotic-mediated effect of human AHR
activity in eye imaginal disks of GMR-GAL4/UAS-AhR
larvae also resulted in three modes of the target gene
response: an increase in the gene expression, a decrease,
and several genes had no response to the AHR activity
(Table 1, Supplementary Figure 4).
Together, our results suggest that while the
endogenous Drosophila ligands of the human AHR
mostly led to an increase in the expression of the AHR
target genes (Figure 4), the effects of the xenobiotics are

The effects of endogenous and exogenous ligands
on the AHR target gene expression in Drosophila
To assess the ability of xenobiotics to affect
expression of the human AHR target genes in Drosophila
tissues we carried out a preliminary examination to identify
potential human AHR target genes in Drosophila. Based on
our analysis and on previous studies in humans [33–35] we
chose several putative Drosophila homologues of the human
AHR targets genes. All selected Drosophila genes contained
XRE-elements in their regulatory regions (Supplementary
Table 1). This set of putative AHR target genes represents
genes that participate in cell proliferation, differentiation,
and toxic agent biodegradation (Supplementary Table 2).
The Dll-GAL4/UAS-AhR flies raised on the standard
medium with no exogenous ligands demonstrated strong
leg abnormalities (Figure 1C). Therefore, we chose these
animals to examine the effects of endogenous AHR ligands
on the expression of AHR target genes. Comparison of the
levels of mRNA synthesis by RT-PCR in the leg imaginal
discs of the UAS-AhR larvae with the Dll-GAL4/UAS-AhR
larvae developed on the standard medium demonstrated an
increase in the transcription levels of most of the examined
AHR target genes confirming that the leg imaginal disc
tissue may contain endogenous ligand(s) for AHR
activation (Figure 4).

Figure 4: Activation of AHR target genes in leg imaginal discs of Dll>AhR larvae in the absence of exogenous ligands.
mRNA levels in leg imaginal discs of Dll-GAL4/UAS-AhR larvae (red) was compared to control UAS-AhR/+ larvae (blue) developed in
the same conditions. The relative level of mRNA expression was measured using real-time PCR. Data are shown as representative of
two independent experiments. The error bars represent the measurement error. Asterisk means the significant change in gene expression
compared to the control.
www.impactjournals.com/oncotarget
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Table 1. Summarized results of real-time PCR experiments shown on Supplementary Figures 1–4
Gene Ligand
Sox70
St6Gal
Mgat1
GstT4
Cyp6g1
Rel
dl
p53
Myc
dap
Rbf
Jra
Cdc42
Sox70
St6Gal
Mgat1
GstT4
Cyp6g1
Rel
dl
p53
Myc
dap
Rbf
Jra
Cdc42
Sox70
St6Gal
Mgat1
GstT4
Cyp6g1
Rel
dl
p53
Myc
dap
Rbf
Jra
Cdc42

Indirubin
Beta-Naphthoflavone
Central nervous system of larvae (Elav-GAL4 driver)
0
+
+
+
−
+
−
0
+
+
−
+
+
+
0
+
0
+
0
+
+
+
−
+
+
+
Adult brains (Elav-GAL4 driver)
+
+
+
0
0
0
+
+
+
+
+
+
0
0
0
0
+
0
+
0
+
+
0
0
0
0
Ovaries (MTD-GAL4 driver)
0
+
0
0
0
−
+
+
+
+
−
+
0
0
+
−
−
0
+
+
+
0
+
0
0
0

www.impactjournals.com/oncotarget
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Indinol
+
+
+
+
+
+
+
+
+
+
+
+
+
0
0
0
0
+
+
−
−
0
−
+
−
−
+
−
−
0
+
−
−
0
−
0
−
0
+

Oncotarget

Sox70
St6Gal
Mgat1
GstT4
Cyp6g1
Rel
dl
p53
Myc
dap
Rbf
Jra
Cdc42

Eye imaginal discs (GMR-GAL4 driver)
−
+
−
0
0
0
−
0
−
−
0
0
−

pleiotropic depending on the gene and tissue. We detected
both increases, decreases and no effects on the expression
of multiple target genes in four different tissues: eye
imaginal disks, larval central nervous system, adult brain
and adult ovaries (Table 1, Supplementary Figures 1–4).
The most striking increases in the xenobiotic-driven gene
expression were detected in the larval CNS and brain.

0
0
−
0
0
+
0
−
−
−
0
−
−

+
+
0
+
0
+
+
+
+
0
+
0
0

expression by modulating the chromatin structure.
This may explain the detected pleiotropic effects of the
human AHR ligands during development. To test this
hypothesis, we performed experiments using mutant flies
with one null-allele of Polycomb (Pc4), a gene which is
the key member of the PcG of epigenetic regulators and a
component of the PRC1 complex [36–38].
To examine this hypothesis we compared the levels of
expression of the AHR target genes in the heads of wild-type
and Pc4 mutant animals carrying the UAS-AhR transgene.
To avoid the effect of the endogenous ligands, we induced
the expression of the UAS-AhR transgene in eye imaginal
discs (GMR-GAL4 driver), and we only chose genes for
analysis whose transcription levels in eyes decreased in
response to the addition of ligands (beta-Naphthoflavone and
indirubin): Sox70, Mgat1, dl, p53, dаp, and Cdc42 (Table 1,
Supplementary Figure 4B–4C) to the food medium. Indeed,
we detected an increase in the transcription levels of the
human AHR target genes in GMR-GAL4/UAS-AhR; Pc4/+

Transcriptional regulation by AHR is mediated
by the PcG of epigenetic chromatin modifiers
Upon observation of the striking effects of AHR
and its exogenous ligands/xenobiotics on fly development
we hypothesized that some AHR target genes may also
be under regulation by other developmental regulator
networks. In particular, we posed the question whether
some AHR target genes are also under the control of
other developmental regulators, such as the Polycomb
group (PcG) of epigenetic factors, which regulate gene

Figure 5: The increase of AHR target genes expression in heads of GMR-GAL4/UAS-AhR; Pc4/+ imagoes. Flies developed

from larvae grown on medium with added indirubin (green), beta-Naphthoflavone (purple), or standard medium without additives
(blue). mRNA levels were analyzed by real-time PCR in heads dissected from GMR-GAL4/UAS-AhR; Pc4/+ imagoes. Data are shown as
representative of two independent experiments. The error bars represent the measurement error. Asterisk means the reliable change in gene
expression compared to the control.
www.impactjournals.com/oncotarget
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Table 2. The depletion of epigenetic repressors activates AHR target genes expression
Gene
symbol
Sox70
Mgat1
dl
p53
dаp
Сdc42

Pc

+

Indirubin
–
–
–
0
–
–

BNF
0
–
0
–
–
–

Allele of Polycomb and added Inhibitor
Pc+ + UNC1999
Pc−
Ligand
Indirubin
BNF
Indirubin
BNF
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Pc+ + Belinostat
Indirubin
+
+
+
+
+
+

BNF
+
+
+
+
+
+

Summarized results of real-time PCR experiments shown on Supplementary Figures 4–6. “Pc+” column represents the
results for selected genes from Supplementary Figure 4 with decreased or maintained mRNA expression. “Pc−”, “Pc+ +
UNC1999” and “Pc+ + Belinostat” columns represent the results shown on Figure 5 (for “Pc−”) and Figure 6. «+», «–» and
«0» mean the increasing expression, the decreasing expression and no effect, respectively. BNF, beta-Naphthoflavone.
mutants compared to GMR-GAL4/UAS-AhR flies with the
wild-type Pc gene, both of which were grown on the medium
with the exogenous ligands (Figure 5, Table 2).
Given the importance of chromatin modifiers in
cancer and other disease [39–41], significant efforts are
being made to develop small molecule inhibitors of these
enzymes (epigenetic inhibitors) and some are already
available. To confirm the above results for Pc mutant flies
and to examine potential cumulative effects of epigenetic
inhibitors and xenobiotics, we examined the effect of

UNC1999, a specific inhibitor of another key member
of the PcG family, E(z), the only H3K27me3 histone
methyltrasferase and a member of the PRC2 complex, in
flies [42]. In addition, we used belinostat, an inhibitor of
histone deacetylases (HDACs). Both inhibitors led to a
similar general decondensation of the chromatin structure
and, as a result, gene activation. Interestingly, the using
of both inhibitors led to the similar, albeit less robust,
increase in the expression of the AHR target genes in
the presence of both xenobiotics (Figure 6, Table 2). The

Figure 6: The increase of AHR target genes expression in heads of GMR>AhR imagoes. Flies developed from larvae grown

on medium with UNC1999 (A), Belinostat (B), and ligands, indirubin (IR, green) and beta-Naphthoflavone (BNF, purple), or standard
medium without additives (blue). mRNA levels were analyzed by real-time PCR in heads dissected from GMR-GAL4/UAS-AhR imagoes.
Data are shown as representative of two independent experiments. The error bars represent the measurement error. Asterisk means the
reliable change in gene expression compared to the control.
www.impactjournals.com/oncotarget
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results of these experiments suggest that in some tissues
and during certain periods of Drosophila development
many AHR target genes are at the same time regulated
by the chromatin-based epigenetic mechanisms of
transcriptional regulation.

agonists of this receptor, i.e. cause only an increase in
the transcription levels of AHR target genes in mammals
[35]. Unexpectedly, in addition to an increase, we found
a decrease and also unchanged expression levels of the
Drosophila AHR target genes. The range of changes in
the levels of transcription was very wide and time and
tissue-specific for each of the ligands used (Table 1). We
found increases in the transcription levels from several
percentage points in fully differentiated tissues up to
several hundred folds in tissues with actively proliferating
cells. The decrease in transcription was from a few percent
to almost complete suppression (Supplementary Figures
1–4). We concluded that the human AHR may have tissueand cell-specific effects on its target genes and that these
effects are diverse and depend on the nature of the ligands,
target genes and on the developmental stage. Importantly,
our work is the first to show that Drosophila may serve as
an important model organism to assess complex pleitropic
effects of xenobiotics on the activity of the human AHR.

DISCUSSION
Endogenous ligands activate human AHR in
the Drosophila leg and wing imaginal discs and
during embryogenesis
Our phenotypic analysis revealed that ectopic
expression of human AHR in various Drosophila organs
and tissues affected their development. Interestingly, in
some tissues, the effect was detected in the absence of
exogenous ligands, while in other tissues it occurred only
in the presence of exogenous ligands/xenobiotics. For
example, the induction of ectopic expression of UAS-AhR
by the tub-GAL4, Act-GAL4, dpp-GAL4 and Dll-GAL4
drivers, caused phenotypic effects in the absence of the
exogenous AHR ligands. This suggests that endogenous
ligands can activate the human AHR in the Drosophila
embryo, as well as in the wing and leg imaginal discs.
Further molecular analysis of the expression of the AHR
target genes in the leg imaginal discs confirmed our
conclusion: the transcription levels of the majority of
these genes increased despite the absence of exogenous
ligands capable of activating of AHR (Figure 4). Since
Dll-GAL4 drives UAS-AhR expression in the tarsal cap and
the proximal ring of the leg imaginal discs in a very small
number of cells comparative to the remaining bulk of the
disc cells [43], the observed increase in the transcription
levels of the AHR target genes is likely to be quite
high. This ability of the human AHR to respond to the
endogenous invertebrate ligands indicates a conservation
of the structural and functional features of the AhR gene
during the evolution of eukaryotes.
It is important to note that both the Dll-GAL4 and
dpp-GAL4 drivers activate UAS-mediated human AHR
expression in the leg imaginal discs, but the phenotypic
effects of human AHR activation by endogenous ligands
(defective leg segmentation) were observed only in the
UAS-AhR/+;Dll-GAL4/+ flies (Figure 1C). Since Dll-GAL4
and dpp-GAL4 drivers have different expression patterns
within the leg imaginal discs, this indicates that the effect of
the endogenous ligands on AHR activity is not only tissue,
but also cell-type specific. Accordingly, in tissues with no
Drosophila endogenous ligands capable of activating the
human AHR, its activation requires exogenous xenobiotics.

Transcriptional regulation by AHR is linked to
developmental activities of epigenetic modulators
of chromatin structure
It is possible that our inability to detect expected
increases in the expression of some AHR target genes in
particular tissues may reflect the tight chromatin architecture
of the target gene regulatory regions. This tight chromatin
may impede the accessibility of the DNA binding sites to
the AHR/ARNT transcription complex. The condensed
structure of nucleosomes is usually associated with particular
modifications of nucleosomal histones, such as a lack of
acetylated residues and the presence of methylated residues,
particularly in H3K27me3. These condensed, repressive
chromatin structures are the products of the activities of
the HDACs and PcG complexes, PRC1 (containing Pc)
and PRC2 (containing histone methyltrasferase E(z)). In
concert, these protein complexes are involved in epigenetic
gene silencing by condensing the structure of chromatin
[44–48].
Indeed, we confirmed this hypothesis by showing that
genetic depletion of Pc, inhibition of HDACs by belinostat,
and inhibition of E(z) H3K27me3 activity by UNC1999
leads to an increase in the expression of some AHR target
genes using ectopic expression of the human AHR and
some of its exogeneous ligands (Figures 5–6, Table 2).
The importance of this study is that it presents
Drosophila as a valid model organism to study the in vivo
effects of xenobiotics, i.e. the ligands of the human AHR
during development. This is facilitated by the limited
effects of the endogenous ligands in this model organism.
An additional advantage of this model is that it provides
the ability to study the input of the epigenetic modifiers
in the functioning of the human AHR in the context of
the organism, where these factors were discovered and
best studied during development. In recent years, the

Using Drosophila as a model to assess function of
the human AHR
To activate human AHR by exogenous ligands,
we used only molecules which are known to act as
www.impactjournals.com/oncotarget
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effect of the exogenous AHR ligands on different types
of cancer has been intensively studied. As a result, new
anticancer agents were discovered and set into production
[49, 50]. However, their effect is not selective and strongly
depends on the type of tumor [49]. At the same time, many
pharmaceutical companies are rapidly developing small
molecule inhibitors of histone-modifying enzymes, such
as UNC1999 or HDAC inhibitors, with the hope that they
can also be used as anti-cancer drugs [51, 52]. Importantly,
our studies provide the first result that may merge both
approaches in vivo, in that we found that inhibition of
the activities of the PcG genes can modulate the action
of the AHR exogenous ligands. Our results imply that in
treating disease conditions caused by xenobiotics, it is
essential to consider the applications of different types of
pharmaceutical agents, not only affecting the effects of
xenobiotics, but also affecting enzymes which modulate
transcription of common target genes through changes in
chromatin structure.

indirubin - 25 mkg/g medium, indole-3-carbinol - 10 mg/g
medium, UNC1999 - 20 mkg/g medium, belinostat - 20
mkg/g medium.
Ligands and inhibitors were fed to imago or larval
offspring obtained after crossing the GAL4-driver flies
with UAS-AhR flies. Parents were kept on standard
Formula 4-24 medium, and then the larval offspring of late
2nd stage was selected for feeding experiments. Larvae
and flies were kept at room temperature (25ºC).
To obtain flies with GMR-GAL4/UAS-AhR; Pc4/+
genotype we crossed UAS-AhR; Pc4p1e5/TM6C females
with GMR-GAL4/Cy0 males and flies without balancer
chromosomes were further selected in the offspring.

Generation of transgenic UAS-AhR flies
Homo sapiens AhR cDNA was taken from pCMV6XL4 construct obtained from OriGene Technologies, Inc.,
clone SC119159 (NM_001621.2). A 5 kb human cDNA
was cloned into the Not I restriction site in the pUAST
vector. The correct orientation of the insert was proven by
sequencing. The resulting UAS-AhR plasmid construct was
injected into the early-stage (w1118) embryos using standard
technique for the P-element dependent transformation
[53], and w+-positive transformants were selected by
standard genetic methods to select Drosophila UAS-AhR
transgenic line. The site of the UAS-AhR insertion was
genetically mapped on the 2nd chromosome.
The presence of the human UAS-AhR construct in
Drosophila genome was confirmed by PCR using a pair
of Ahr1f and Ahr1rev primers (Supplementary Figure 5A).
Inverse PCR analysis revealed that only one copy of UASAhR was inserted in 60Е11 cytological region between
CG30424 and Rpl19 loci (40 bp upstream of unknown
CG30424 and approximately 540 bp downstream of
Rpl19). Proper UAS-mediated inducible expression of the
human UAS-AhR transgene was confirmed by RT-PCR and
Western blot analysis of progeny obtained from crossing
of UAS-AhR and Elav-GAL4 flies, grown on the standard
medium and the medium with indinol (Supplementary
Figure 5B–5С). PCR, RT-PCR and Western blot analysis
were performed according to standard protocols [54].
Tubulin was used as the control for normalization.
Polyclonal rabbit antibody Anti-AHR was used in dilution
1:1000 (PA5-29642, ThermoFisherScientific, USA).
Mouse antibody Anti-Actin clone C4 was used in dilution
1:1000 (MAB1501, Merck Millipore, USA).

MATERIALS AND METHODS
Fly Stocks, Rearing Conditions and Reagents
UAS-AhR strain with inducible human AhR gene
expression was obtained in this study as described
below. Wild type Oregon R, w1118 and GAL4-driver lines
were obtained from the Bloomington Drosophila stock
center. The following GAL4 lines were used to drive the
expression of the UAS-AhR construct: for ubiquitous
expression - tub-GAL4 (genotype: y1w*; P{tubP-GAL4}
LL7/TM3,Sb1Ser1) and Act-GAL4 (genotype: y1w*;
P{Act5C-GAL4-w}E1/CyO); for expression in leg and
wing imaginal disks - dpp-GAL4 (genotype: y1w67c23;
P{dpp-GAL4.PS}6A/TM6,Tb1) and Dll-GAL4 (genotype:
P{GawB}Dllmd23/CyO); in eye imaginal disks - GMRGAL4 (genotype: w*; P{GAL4-ninaE.GMR}12); in the
central nervous systems - Elav-GAL4 (genotype: P{GawB}
elavC155, P{UAS-mCD8::GFP.L}Ptp4ELL4, P{hsFLP}1,
w*/FM7c), in germ line cells - MTD-GAL4 (genotype:
P{otu-GAL4::VP16.R}1, w*; P{GAL4-nos.NGT}40;
P{GAL4::VP16-nos.UTR}CG6325MVD1). Pc4p1e5/TM6C
and UAS-GFP lines are the gift from Dr. Maxim Erokhin
(Institute of Gene Biology Russian Academy of Science).
In genetic experiments we used standard Formula
4-24 medium (Carolina Biological Supply, USA).
Following ligands were used: 2′Z-Indirubin (SML0280,
Sigma-Aldrich, USA), beta-Naphthoflavone (A18543,
Alfa Aesar, Thermo Fisher Scientific, UK), Indole-3Carbinol (indinol, Mirax Biopharma, Russia). Following
inhibitors were used: UNC1999 (SML0778, SigmaAldrich, USA), belinostat (PXD101, Sigma-Aldrich,
USA). Ligands and inhibitors were diluted in solution
according to the manufacturer’s protocol and added
to the Formula 4-24 medium at a corresponding final
concentration: beta-Naphthoflavone - 200 mkg/g medium,
www.impactjournals.com/oncotarget

Real-time reverse-transcription PCR analysis
Flies/larvae/organs were frozen in liquid
nitrogen and total RNA was extracted using RNAzol
RT reagent (Sigma-Aldrich, USA) according to the
manufacturer’s specifications. RNA Samples were
treated with DNase (Turbo DNA-free kit, Applied
BioSystems, Life Technologies, USA) according to
102943
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the manufacturer’s protocol to remove genomic DNA
contamination. cDNA was synthesized from 1–5 µg of
total RNA, using a cDNA synthesis kit with oligo-dT
priming (Thermo Fisher Scientific, USA). The levels
of mRNA expression were measured with Real-Time
Quantitative Reverse Transcription PCR using TaqMan®
probes (Syntol, Russia). All reactions were carried out
in triplicate. Real-time PCR was conducted using an
ABI Prism 7500 Sequence Detection System (Applied
BioSystems, Life Technologies, USA). The 2-ΔΔCt
method was chosen as the calculation method [55]. The
difference in the cycle threshold (Ct) value of the target
gene and its housekeeping gene (Rpl32) called ΔCt was
calculated using the following equation: ΔΔCt = (ΔCt
of ligand treated flies) – (ΔCt of the untreated control
flies). Sequences of primer pairs and TaqMan® probes are
summarized in Supplementary Table 3.
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Immunohistochemistry
Ovaries were dissected in PBS and fixed for
15 min in 4% paraformaldehyde in PBS + 0.2%
Triton X-100. Following fixation, samples were
rinsed 3 times with PBS + 0.2% Triton X-100,
incubated for 1 hr in CF594 Phalloidin (Biotium, 1:40
dilution), then rinsed 3 times in PBS. Ovaries were
incubated for 15 min in RNase A (100 mg/ml),
and rinsed again 3 times with PBS and incubated for
15 min in SytoxGreen (Thermo Fisher Scientific, 1:500
dilution), washed with PBS, and mounted in Vectashield
mounting medium (H-1000, Vector laboratories).
For preparation and examination of larval CNS, the
3rd instar larvae were immediately washed with ice cold
PBS and kept on ice until dissection. Dissected larval CNS
were fixed in 4% paraformaldehyde in PBS for 20 min,
washed three times in PBS and mounted in Vectashield
mounting medium (H-1000, Vector laboratories). GFP was
visualized without staining.
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Microscopic analysis
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